Pilocarpine is a cholinergic agonist, right? It acts on muscarinic receptors. Mainly, it's used in glaucoma to reduce intraocular pressure by increasing aqueous outflow. Oh, and it's also used in xerostomia, like in Sjögren's syndrome or after head and neck radiation to stimulate saliva production.

Wait, what about other conditions? It's sometimes used in the management of accommodative spasm, but not sure. For glaucoma, it's a miotic agent, constricting the pupil to open the trabecular meshwork. So if the options include something like mydriasis or hyperopia, that would be incorrect. But the question is about the exception. Let's say the options are A: Glaucoma, B: Xerostomia, C: Hyperopia, D: Sjögren's syndrome. Then the answer would be C because pilocarpine causes miosis, not mydriasis, and isn't used for hyperopia. It's used for conditions where increasing parasympathetic activity helps. So each wrong option should be explained as to why they're incorrect. The clinical pearl would be that pilocarpine is a miotic used in glaucoma and for dry mouth, not for conditions requiring pupil dilation.

**Core Concept**
Pilocarpine is a direct-acting cholinergic agonist that stimulates **muscarinic receptors**, primarily used to reduce intraocular pressure in glaucoma and treat xerostomia. Its mechanism involves **increasing aqueous humor outflow** and **stimulating salivary glands**.

**Why the Correct Answer is Right**
The **exception** is **Hyperopia (farsightedness)**. Pilocarpine causes **miosis** (pupil constriction) by contracting the iris sphincter muscle, which is beneficial in angle-closure glaucoma but irrelevant for refractive errors like hyperopia. It does not alter refractive power or correct visual acuity issues.

**Why Each Wrong Option is Incorrect**
**Option A:** *Glaucoma* – Correct use; pilocarpine reduces intraocular pressure.
**Option B:** *Xerostomia* – Correct use; stimulates salivary secretion in Sjögren’s syndrome.
**Option D:** *Sjögren’s syndrome* – Correct use; targets xerostomia (dry mouth) via muscarinic stimulation.

**Clinical Pearl / High-Yield Fact**
Pilocarpine is a **miotic agent** contraindicated in patients with narrow-angle glaucoma *unless* used to manage acute attacks. Remember: **"Pilocarpine pinches the pupil"** to open trabecular meshwork in angle-closure glaucoma.

**Correct Answer: C. Hyperopia**